Evidence map›Paper›PMID 37541187›Full record

ArticleAmerican journal of human genetics2023

Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.

Yijun Tian, Dandan Dong, Zixian Wang, Lang Wu, Jong Y Park, PRACTICAL consortium, Gong-Hong Wei, Liang Wang

Open access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Pathogenic Roles for RNASET2 in Clear Cell Renal Cell Carcinoma.Laboratory investigation; a journal of technical methods and pathology · 2024
    Article
  11. SWI/SNF chromatin remodelers in prostate cancer progression.Frontiers in epigenetics and epigenomics · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Yijun TianDepartment of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.
Dandan DongMOE Key Laboratory of Metabolism and Molecular Medicine, Shanghai Medical College of Fudan University, Shanghai, China.
Zixian WangMOE Key Laboratory of Metabolism and Molecular Medicine, Shanghai Medical College of Fudan University, Shanghai, China; Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences, Shanghai Medical College of Fudan University, Shanghai, China; Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
Lang WuPopulation Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI 96813, USA.
Jong Y ParkDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
PRACTICAL consortium
Gong-Hong WeiMOE Key Laboratory of Metabolism and Molecular Medicine, Shanghai Medical College of Fudan University, Shanghai, China; Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences, Shanghai Medical College of Fudan University, Shanghai, China; Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China; Disease Networks Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland; Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland. Electronic address: gonghong_wei@fudan.edu.cn.
Liang WangDepartment of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA. Electronic address: liang.wang@moffitt.org.
Moffitt Cancer Center · USShanghai Medical College of Fudan University · CNUniversity of Hawaiʻi at Mānoa · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
Uncovering causal protein markers to improve prostate cancer etiology understanding and risk prediction in Africans and EuropeansR01CA263494 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Chong Wu, Lang Wu · 2022 to 2026
$3.5M
Cell free nucleic acid-based biomarkers in advanced prostate cancerR01CA212097 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI KOHLI, MANISH, WANG, LIANG · 2017 to 2022
$3.1M
Functional characterization of prostate cancer risk loci by high throughput sequencingR01CA250018 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI WANG, LIANG · 2020 to 2023
$1.5M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA212097NCI NIH HHS R01 CA250018NCI NIH HHS R01 CA263494
6 · The paper itself

Abstract

Genome-wide association studies along with expression quantitative trait locus (eQTL) mapping have identified hundreds of single-nucleotide polymorphisms (SNPs) and their target genes in prostate cancer (PCa), yet functional characterization of these risk loci remains challenging. To screen for potential regulatory SNPs, we designed a CRISPRi library containing 9,133 guide RNAs (gRNAs) to cover 2,166 candidate SNP loci implicated in PCa and identified 117 SNPs that could regulate 90 genes for PCa cell growth advantage. Among these, rs60464856 was covered by multiple gRNAs significantly depleted in screening (FDR < 0.05). Pooled SNP association analysis in the PRACTICAL and FinnGen cohorts showed significantly higher PCa risk for the rs60464856 G allele (p value = 1.2 × 10

Indexed as

ProstateProstatic NeoplasmsAllelesAnimalsATPases Associated with Diverse Cellular ActivitiesCarrier ProteinsCCCTC-Binding FactorCohesinsDNA HelicasesEarly Detection of CancerGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMaleMicePolymorphism, Single NucleotideATPases Associated with Diverse Cellular ActivitiesCarrier ProteinsCCCTC-Binding FactorCohesinsCTCF protein, humanDNA HelicasesRUVBL1 protein, humanbase editingcohesinCRISPRi screeningCTCFeQTLnoncoding variationpost-GWAS function analysisprostate cancer riskRUVBL1SILAC proteomics

Identifiers

PMID37541187
PMCPMC10432188
OpenAlexW4385546281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.